HUM (Humana Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by HUM officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-03 | Shantanu Nundy | Chief Medical Officer | A | — | — |
| 2026-08-04 | Frederick John Crawford | Director | A | — | — |
| 2026-08-04 | Paul John Smith | Director | A | — | — |
| 2026-07-02 | KURT J HILZINGER | Director | A | — | — |
| 2026-05-05 | Aaron Martin | President, Medicare Advantage | A | — | — |
| 2026-05-05 | Sanjay K Shetty | President, CenterWell | A | — | — |
| 2026-05-05 | Joseph C Ventura | Chief Legal Officer | A | — | — |
| 2026-05-05 | Robert Stuart Field | Director | A | — | — |
| 2026-05-05 | Michelle A. O'Hara | Chief Human Resources Officer | A | — | — |
| 2026-05-05 | James A. Rechtin | President & CEO | A | — | — |
| 2026-05-05 | David Dintenfass | President, Enterprise Growth | A | — | — |
| 2026-05-05 | Japan Mehta | Chief Information Officer | A | — | — |
| 2026-05-05 | Celeste Mellet | Chief Financial Officer | A | — | — |
| 2026-04-03 | Sanjay K Shetty | President, CenterWell | MIXED | — | — |
| 2026-04-02 | KURT J HILZINGER | Director | A | — | — |
| 2026-04-02 | George Renaudin II | President, Insurance | J | — | — |
| 2026-02-26 | George Renaudin II | President, Insurance | MIXED | — | — |
| 2026-02-26 | Joseph C Ventura | Chief Legal Officer | MIXED | — | — |
| 2026-02-25 | Sanjay K Shetty | President, CenterWell | Buy | — | — |
| 2026-02-25 | John-Paul W. Felter | SVP, Chief Accting Off & Cont. | MIXED | — | — |
| 2026-02-24 | David Dintenfass | President, Enterprise Growth | MIXED | — | — |
| 2026-02-18 | Celeste Mellet | Chief Financial Officer | MIXED | — | — |
| 2026-02-18 | Japan Mehta | Chief Information Officer | MIXED | — | — |
| 2026-02-17 | Aaron Martin | President, Medicare Advantage | A | — | — |
| 2026-01-12 | James A. Rechtin | President & CEO | MIXED | — | — |
| 2026-01-05 | Michelle A. O'Hara | Chief Human Resources Officer | MIXED | — | — |
| 2026-01-05 | Raquel C. Bono | Director | A | — | — |
| 2026-01-05 | Gordon Smith | Director | A | — | — |
| 2026-01-05 | KAREN KATZ | Director | A | — | — |
| 2026-01-05 | KURT J HILZINGER | Director | A | — | — |
| 2026-01-05 | Jorge S. Mesquita | Director | A | — | — |
| 2026-01-05 | FRANK A DAMELIO | Director | A | — | — |
| 2026-01-05 | Marcy S Klevorn | Director | A | — | — |
| 2026-01-05 | John W Garratt | Director | A | — | — |
| 2026-01-05 | Wayne A.I. Frederick | Director | A | — | — |
| 2026-01-05 | David T Feinberg | Director | A | — | — |
| 2025-12-17 | John-Paul W. Felter | SVP, Chief Accting Off & Cont. | MIXED | — | — |
| 2025-12-17 | George Renaudin II | President, Insurance | MIXED | — | — |
| 2025-12-17 | Joseph C Ventura | Chief Legal Officer | MIXED | — | — |
| 2025-12-17 | James A. Rechtin | President & CEO | MIXED | — | — |
| 2025-12-17 | Michelle A. O'Hara | Chief Human Resources Officer | MIXED | — | — |
| 2025-12-17 | Sanjay K Shetty | President, CenterWell | MIXED | — | — |
| 2025-12-17 | David Dintenfass | President, Enterprise Growth | MIXED | — | — |
| 2025-12-17 | Japan Mehta | Chief Information Officer | MIXED | — | — |
| 2025-12-17 | Celeste Mellet | Chief Financial Officer | MIXED | — | — |
| 2025-11-04 | Gordon Smith | Director | M | — | — |
| 2025-10-03 | George Renaudin II | President, Insurance | MIXED | — | — |
| 2025-10-02 | Gordon Smith | Director | A | — | — |
| 2025-10-02 | KURT J HILZINGER | Director | A | — | — |
| 2025-10-02 | David T Feinberg | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 144,285 | — |
| — | Senior Vice President | 134,072 | — |
| — | President - Retail Segment | 117,542 | — |
| — | Chief Executive Officer | 110,130 | — |
| — | President & CEO | 67,631 | — |
| — | Vice President & Chief Actuary | 59,513 | — |
| — | Sr VP & Chief Innovation Off. | 55,507 | — |
| — | Director | 39,814 | — |
| — | Chief Financial Officer | 39,637 | — |
| — | EVP & COO | 37,608 | — |
| — | Director | 32,820 | — |
| — | Director | 31,852 | — |
| — | Sr. VP-Chief Marketing Officer | 31,146 | — |
| — | Sr. VP, CFO & Treasurer | 30,326 | — |
| — | Chief Legal Officer | 27,699 | — |
| — | President, Enterprise Growth | 25,407 | — |
| — | President, Medicare Advantage | 25,237 | — |
| — | Chief Financial Officer | 24,342 | — |
| — | Sr. VP | 23,408 | — |
| — | Chief Financial Officer | 22,384 | — |
| — | President, CenterWell | 22,088 | — |
| — | Chief Human Resources Officer | 20,026 | — |
| — | Director | 19,448 | — |
| — | Former Sr VP | 19,347 | — |
| — | Sgmt Pres, Healthcare Services | 18,756 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the HUM quote page; the site-wide leaderboard is on the insider transactions hub.